Related references
Note: Only part of the references are listed.Depletion of Trp53 and Cdkn2a Does Not Promote Self-Renewal in the Mammary Gland but Amplifies Proliferation Induced by TNF-α
Linda J. van Weele et al.
STEM CELL REPORTS (2021)
Transgenic mouse models of breast cancer
Angelina T. Regua et al.
CANCER LETTERS (2021)
Acquired Resistance to KRASG12C Inhibition in Cancer
M. M. Awad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A06 Tri-complex Inhibitors of the Oncogenic, GTP-Bound Form of KRASG12C Overcome RTK-Mediated Escape Mechanisms and Drive Tumor Regressions in Preclinical Models of NSCLC
R. Nichols et al.
Journal of Thoracic Oncology (2020)
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
David S. Hong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The Genome of C57BL/6J Eve, the Mother of the Laboratory Mouse Genome Reference Strain
Vishal Kumar Sarsani et al.
G3-GENES GENOMES GENETICS (2019)
EMT: A mechanism for escape from EGFR-targeted therapy in lung cancer
Eugene Tulchinsky et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
Comprehensive Outline of Whole Exome Sequencing Data Analysis Tools Available in Clinical Oncology
Aron Bartha et al.
CANCERS (2019)
Tri-complex inhibitors of the oncogenic, GTP-bound form of KRASG12c overcome RTK-mediated escape mechanisms and drive tumor regressions in vivo
Christopher J. Schulze et al.
MOLECULAR CANCER THERAPEUTICS (2019)
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers
Ashton C. Berger et al.
CANCER CELL (2018)
Genomic and Functional Approaches to Understanding Cancer Aneuploidy
Alison M. Taylor et al.
CANCER CELL (2018)
Comprehensive Characterization of Cancer Driver Genes and Mutations
Matthew H. Bailey et al.
CELL (2018)
The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update
Enis Afgan et al.
NUCLEIC ACIDS RESEARCH (2018)
Identification of Drivers of Aneuploidy in Breast Tumors
Katherine Pfister et al.
CELL REPORTS (2018)
Histological subtypes of mouse mammary tumors reveal conserved relationships to human cancers
Daniel P. Hollern et al.
PLOS GENETICS (2018)
Community-Driven Data Analysis Training for Biology
Berenice Batut et al.
CELL SYSTEMS (2018)
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
Pedram Razavi et al.
CANCER CELL (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
Vikram R. Juneja et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability
Anne-Pierre Morel et al.
NATURE MEDICINE (2017)
Kras mutant genetically engineered mouse models of human cancers are genomically heterogeneous
Wei-Jen Chung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
G. V. Long et al.
ANNALS OF ONCOLOGY (2017)
MultiQC: summarize analysis results for multiple tools and samples in a single report
Philip Ewels et al.
BIOINFORMATICS (2016)
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes (vol 7, 11479, 2016)
Bernard Pereira et al.
NATURE COMMUNICATIONS (2016)
The landscape of chromosomal aberrations in breast cancer mouse models reveals driver-specific routes to tumorigenesis
Uri Ben-David et al.
NATURE COMMUNICATIONS (2016)
DNA aneuploidy and breast cancer: a meta-analysis of 141,163 cases
Jing Xu et al.
ONCOTARGET (2016)
Large variety in a panel of human colon cancer organoids in response to EZH2 inhibition
Martijn A. J. Koppens et al.
ONCOTARGET (2016)
Barcoding reveals complex clonal dynamics of de novo transformed human mammary cells
Long V. Nguyen et al.
NATURE (2015)
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
Xiaofeng Zheng et al.
NATURE (2015)
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
Kari R. Fischer et al.
NATURE (2015)
HISAT: a fast spliced aligner with low memory requirements
Daehwan Kim et al.
NATURE METHODS (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data
F. Favero et al.
ANNALS OF ONCOLOGY (2015)
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Yang Liao et al.
BIOINFORMATICS (2014)
Development of an Immunologically Tolerated Combination of Fluorescent Proteins for In vivo Two-photon Imaging
Selamawit Gossa et al.
SCIENTIFIC REPORTS (2014)
Identification of a MHC I-restricted epitope of DsRed in C57BL/6 mice
Gayle M. Davey et al.
MOLECULAR IMMUNOLOGY (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Anirudh Prahallad et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
Amplification of the Driving Oncogene, KRAS or BRAF, Underpins Acquired Resistance to MEK1/2 Inhibitors in Colorectal Cancer Cells
Annette S. Little et al.
SCIENCE SIGNALING (2011)
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Lecia V. Sequist et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
A Gene Expression Signature Associated with K-Ras Addiction Reveals Regulators of EMT and Tumor Cell Survival
Anurag Singh et al.
CANCER CELL (2009)
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie et al.
NATURE (2009)
Oncogene cooperation in tumor maintenance and tumor recurrence in mouse mammary tumors induced by Myc and mutant Kras
Katrina Podsypanina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A global double-fluorescent cre reporter mouse
Mandar Deepak Muzumdar et al.
GENESIS (2007)
Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis
Christopher J. Sarkisian et al.
NATURE CELL BIOLOGY (2007)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The transcriptional repressor snail promotes mammary tumor recurrence
SE Moody et al.
CANCER CELL (2005)
Oncogene-induced senescence as an initial barrier in lymphoma development
M Braig et al.
NATURE (2005)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
VK Mootha et al.
NATURE GENETICS (2003)
Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened
JK Chen et al.
GENES & DEVELOPMENT (2002)
Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes
GH Fisher et al.
GENES & DEVELOPMENT (2001)
The enhanced green fluorescent protein (eGFP) is minimally immunogenic in C57BL/6 mice
D Skelton et al.
GENE THERAPY (2001)
Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer
J Jonkers et al.
NATURE GENETICS (2001)
EGFP-transduced EL-4 cells form tumors in C57BL/6 mice
M Denaro et al.
GENE THERAPY (2001)
Share Paper
